Hemagen Diagnostics Inc HMGN:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 12/06/23 EDT
0.00UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date10/23/23
  • 52 Week Low0.00
  • 52 Week Low Date12/06/23

Key Stats

  • Market Cap15.50
  • Shares Out15.50M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta0.60
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date10/23/23
  • 52 Week Low0.00
  • 52 Week Low Date12/06/23
  • Market Cap15.50
  • Shares Out15.50M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta0.60
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.06
  • P/E (TTM)-0.00
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-273,669.988
  • ROE (TTM)-
  • Revenue (TTM)4.042M
  • Gross Margin (TTM)39.92%
  • Net Margin (TTM)-22.45%
  • Debt To Equity (MRQ)-141.33%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Hemagen Diagnostics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Hemagen Diagnostics, Inc. is engaged in providing clinical diagnostic solutions. The Company is primarily focused on Veterinary Clinical Diagnostics. It is also focused on VIRGO, its Human Clinical Diagnostic line of autoimmune and infectious disease products. The Company develops, manufactures and markets a range of test kits used to aid in the diagnosis of certain autoimmune and infectious diseases. The Company’s autoimmune product portfolio includes Hemagen DNA Kit...
William Hales
Chairman of the Board, President, Chief Executive Officer
M. Robert Campbell
Chief Financial Officer
Catherine Davidson
Principal Accounting Officer, Controller
Address
9033 Red Branch Rd
Columbia, MD
21045-2396
United States